Skip Nav Destination
Issues
ARTICLES
Target cell lysis by cytotoxic T lymphocytes that lack detectable hemolytic perforin activity.
J Immunol (1988) 141 (10): 3243–3248.
Differential activation requirements for virgin and memory T cells.
J Immunol (1988) 141 (10): 3249–3257.
Activation events in hapten-specific B cells from tolerant mice.
J Immunol (1988) 141 (10): 3258–3262.
Antigen processing and the human T cell receptor repertoire for insulin.
J Immunol (1988) 141 (10): 3293–3298.
Selective inhibition of antigen presentation to cloned T cells by protease inhibitors.
J Immunol (1988) 141 (10): 3313–3317.
Subtypes of helper cells. Non-inflammatory type 1 helper T cells.
J Immunol (1988) 141 (10): 3329–3334.
B cells expressing Ig transgenes respond to a T-dependent antigen only in the presence of Ia-compatible T cells.
J Immunol (1988) 141 (10): 3335–3341.
In vivo and in vitro production of IFN-beta and IFN-gamma during graft vs host disease.
J Immunol (1988) 141 (10): 3349–3356.
Regulation of antibody production by helper T cell clones in experimental autoimmune myasthenia gravis.
J Immunol (1988) 141 (10): 3361–3369.
Pre-exposure of human B cells to recombinant IL-1 enhances subsequent proliferation.
J Immunol (1988) 141 (10): 3398–3404.
IL-4 induces loss of B lymphocyte Fc gamma R II ligand binding capacity.
J Immunol (1988) 141 (10): 3416–3421.
Limiting dilution analysis of TNF producing cells in C3H/HeJ mice.
J Immunol (1988) 141 (10): 3422–3428.
Characterization of protein kinase C and its isoforms in human T lymphocytes.
J Immunol (1988) 141 (10): 3463–3470.
Characterization of granzymes A and B isolated from granules of cloned human cytotoxic T lymphocytes.
J Immunol (1988) 141 (10): 3471–3477.
Functional and biochemical analysis of CD16 antigen on natural killer cells and granulocytes.
J Immunol (1988) 141 (10): 3478–3485.
An 80 to 85 kilodalton human phosphoglycoprotein associated with cell activation.
J Immunol (1988) 141 (10): 3492–3497.
Is a natural ligand of the T lymphocyte CD2 molecule a sulfated carbohydrate?
J Immunol (1988) 141 (10): 3498–3504.
Identification and partial characterization of human platelet C1q binding sites.
J Immunol (1988) 141 (10): 3505–3511.
Possible association between IL-2 receptors and class I HLA molecules on T cells.
J Immunol (1988) 141 (10): 3512–3515.
The physical-chemical characterization and biologic activity of serum released lipopolysaccharides.
J Immunol (1988) 141 (10): 3523–3531.
Tyrosine phosphorylation of the human T cell antigen receptor zeta-chain: activation via CD3 but not CD2.
A M Weissman; P Ross; E T Luong; P Garcia-Morales; M L Jelachich; W E Biddison; R D Klausner; L E Samelson
J Immunol (1988) 141 (10): 3532–3536.
The in vivo production of peptide leukotrienes after pulmonary anaphylaxis in the rat.
J Immunol (1988) 141 (10): 3544–3550.
Group B streptococci inhibit the chemotactic activity of the fifth component of complement.
J Immunol (1988) 141 (10): 3551–3556.
Agents that mimic antigen receptor signaling inhibit proliferation of cloned murine T lymphocytes induced by IL-2.
J Immunol (1988) 141 (10): 3557–3563.
Human C5a and C5a des Arg exhibit chemotactic activity for fibroblasts.
J Immunol (1988) 141 (10): 3570–3574.
Molecular analysis of the gene encoding the major surface antigen of Toxoplasma gondii.
J Immunol (1988) 141 (10): 3584–3591.
Protection of mice against Japanese encephalitis virus by passive administration with monoclonal antibodies.
J Immunol (1988) 141 (10): 3606–3610.
Comparative immunogenicity of hepatitis B virus core and E antigens.
J Immunol (1988) 141 (10): 3617–3624.
Isolation and analysis of murine serum amyloid P component cDNA clones.
J Immunol (1988) 141 (10): 3642–3646.
Defective E beta expression in three mouse H-2 haplotypes results from aberrant RNA splicing.
J Immunol (1988) 141 (10): 3647–3653.
Molecular basis for the defective expression of the mouse Ew17 beta gene.
J Immunol (1988) 141 (10): 3654–3661.
Bispecific F(ab' gamma)2 antibody for the delivery of saporin in the treatment of lymphoma.
J Immunol (1988) 141 (10): 3662–3670.
Enhancement of human monocyte tumoricidal activity by recombinant M-CSF.
J Immunol (1988) 141 (10): 3680–3686.
-
Cover Image
Cover Image
- PDF Icon PDF LinkTable of Contents
Advertisement
Advertisement